Twist Bioscience Corp (TWST) - Comprehensive Stock Analysis & Investment Research
Deep dive into Twist Bioscience Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Twist Bioscience Corp Investment Summary
When evaluating whether Twist Bioscience Corp (TWST) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Twist Bioscience Corp (TWST) operates within the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. . With a market capitalization of $10 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Twist Bioscience Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Twist Bioscience Corp along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Twist Bioscience Corp is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Twist Bioscience Corp (Stock Symbol: TWST) is a prominent company operating within the Life Sciences sector, with a specific focus on the Biological Products, (No Diagnostic Substances) industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Twist Bioscience Corp's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Twist Bioscience Corp...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Twist Bioscience Corp...
Revenue & Growth Analysis
Twist Bioscience Corp generates annual revenues of $431 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Twist Bioscience Corp...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Twist Bioscience Corp...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Twist Bioscience Corp...
Strategic Market Position
Twist Bioscience Corp strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Twist Bioscience Corp competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company currently shows negative free cash flow of $-93 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a 51.9% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.
Operating margin of -33.6% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.64x indicates moderate asset turnover. Lower turnover is expected where the business model requires significant infrastructure, so the ratio should be read against the company's own industry.
Financial Strength & Leverage
Current ratio of 2.67 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.